Advertisement

First-in-human 18F-SiFAlin-TATE PET/CT for NET imaging and theranostics

  • Harun IlhanEmail author
  • A. Todica
  • S. Lindner
  • G. Boening
  • A. Gosewisch
  • C. Wängler
  • B. Wängler
  • R. Schirrmacher
  • P. Bartenstein
Image of the Month
  • 429 Downloads
Part of the following topical collections:
  1. Image of the month

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Informed consent

Written informed consent was obtained from the patient.

References

  1. 1.
    Bodei L, Mueller-Brand J, Baum RP, Pavel ME, Horsch D, O’Dorisio MS, et al. The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2013;40:800–16.  https://doi.org/10.1007/s00259-012-2330-6.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Pavel M, O’Toole D, Costa F, Capdevila J, Gross D, Kianmanesh R, et al. ENETS consensus guidelines update for the management of distant metastatic disease of intestinal, pancreatic, bronchial neuroendocrine neoplasms (NEN) and NEN of unknown primary site. Neuroendocrinology. 2016;103:172–85.  https://doi.org/10.1159/000443167.CrossRefPubMedGoogle Scholar
  3. 3.
    Niedermoser S, Chin J, Wangler C, Kostikov A, Bernard-Gauthier V, Vogler N, et al. In vivo evaluation of (1)(8)F-SiFAlin-modified TATE: a potential challenge for (6)(8)Ga-DOTATATE, the clinical gold standard for somatostatin receptor imaging with PET. J Nucl Med. 2015;56:1100–5.  https://doi.org/10.2967/jnumed.114.149583.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Nuclear MedicineUniversity Hospital of MunichMunichGermany
  2. 2.Biomedical Chemistry, Department of Clinical Radiology and Nuclear MedicineMedical Faculty Mannheim of Heidelberg UniversityMannheimGermany
  3. 3.Molecular Imaging and Radiochemistry, Department of Clinical Radiology and Nuclear MedicineMedical Faculty Mannheim of Heidelberg UniversityMannheimGermany
  4. 4.Department of Oncology, Division of Oncological ImagingUniversity of AlbertaEdmontonCanada

Personalised recommendations